Philips报告2025年Q2财政收益、签署保健协议和推出新的技术。 Philips reports Q2 2025 financial gains, signing health deals and launching new tech.

Philips报告,2025年的Q2财政业绩强劲,定购量增加了6%,销售额增加了1%,达到43亿欧元。 Philips reported strong financial performance for Q2 2025, with a 6% increase in order intake and a 1% rise in sales, reaching €4.3 billion. 该公司经调整的EBITA比值提高了130个基点,达到12.4%,自由现金流动增加到2.3亿欧元。 The company's Adjusted EBITA margin improved by 130 basis points to 12.4%, and free cash flow increased to €230 million. Philips与印度尼西亚卫生部签署了一项协议,以扩大获得高级医疗服务的机会,并推出了新的AI驱动医疗成像软件。 Philips signed a deal with Indonesia's Ministry of Health to expand access to advanced medical care, and launched new AI-powered medical imaging software. 该公司还降低了美国进口关税的估计影响,目前预计当年的成本为1.5亿至2亿欧元。 The company also lowered its estimated impact from US import tariffs, now projecting a cost of €150-200 million for the year.